Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ABCL
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AbCellera Biologics Inc (ABCL) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbCellera Biologics (ABCL) trades at $12.68, up 2.51% with bullish technical momentum. The stock has surged 121% in three months following positive Phase 2 results for ABCL635. Despite negative profitability metrics, analyst consensus remains strong with 91.7% buy ratings and a $15.40 price target. Recent institutional interest includes BlackRock's $48 million investment in Q2 2026, while the company maintains a solid balance sheet with $625.6 million cash.
The outlook hinges on ABCL635's clinical progress and potential commercialization, though execution risks persist given negative cash flow and high SG&A costs. Near-term catalysts include Q3 2026 earnings on November 9, 2026. Investors face volatility from clinical trial outcomes and biotech sector sentiment shifts, balanced by strong institutional backing and analyst optimism.
Read full analysis

Key Stats

  • Market Cap
    $4.11B
  • Volume
    5,752,995
  • Sector
    Health
  • 52W High
    $14.82
  • 52W Low
    $2.78
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $3.70B
  • Div Yield
    -
  • Trading Activity
    27% Sell | 73% Buy
$11.8
52W Low: $2.78
05 Feb 2026
52W High: $14.82
29 Sep 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $14.82, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Most Recent News

Content is generated by Aura AI

Eagle Point Credit trades near lows with 25.3% yield but faces earnings and sustainability concerns.

Eagle Point Credit (ECC) shares are trading at a 33% discount to net asset value and near all-time lows, reflecting investor concerns. Despite a historically high distribution yield of 25.3%, the sustainability of these payouts is questionable follow...

Market News
6 hours ago
Seeking Alpha
Bearish
news icon
Eagle Point Credit trades near lows with 25.3% yield but faces earnings and sustainability concerns.

Law firm probes Navan over IPO disclosures amid lawsuit on marketing expense surge

Kahn Swick & Foti, LLC has launched an investigation into Navan, Inc. following allegations that the company failed to disclose rising sales and marketing expenses during its October 2025 IPO. Navan had reported strong revenue and booking growth, but...

Market News
7 hours ago
PRNewsWire
Bearish
news icon
Law firm probes Navan over IPO disclosures amid lawsuit on marketing expense surge

Changan signs European partnerships and launches local service program to boost market presence

At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...

Market News
8 hours ago
Globe Newswire
Bullish
news icon
Changan signs European partnerships and launches local service program to boost market presence
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $4.11B
  • Volume
    5,752,995
  • Sector
    Health
  • 52W High
    $14.82
  • 52W Low
    $2.78
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $3.70B
  • Div Yield
    -
  • Trading Activity
    27% Sell | 73% Buy
$11.8
52W Low: $2.78
05 Feb 2026
52W High: $14.82
29 Sep 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $14.82, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!